Savara, Inc. (SVRA) Financial Statements (2024 and earlier)

Company Profile

Business Address 6836 BEE CAVE ROAD
AUSTIN, TX 78746
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments125,876161,17182,188121,761110,83094,313
Cash and cash equivalents52,10034,01222,88049,80424,30122,121
Short-term investments73,776127,15959,30871,95786,52972,192
Receivables162306653364421196
Prepaid expense231427453247162158
Other undisclosed current assets2,6853,0961,8271,6951,9313,197
Total current assets:128,954165,00085,121124,067113,34497,864
Noncurrent Assets
Operating lease, right-of-use asset100300200700
Property, plant and equipment5173156352522925
Intangible assets, net (including goodwill)     26,91827,082
Goodwill     26,91827,082
Regulated entity, other noncurrent assets    18226883
Other noncurrent assets116251250673131131
Other undisclosed noncurrent assets10,55610,97412,01810,22911,10433,543
Total noncurrent assets:10,82311,59812,62412,13638,94361,764
TOTAL ASSETS:139,777176,59897,745136,203152,287159,628
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities5,8676,3278,1748,8807,2135,750
Accounts payable1,3341,4432,5953,4093,8792,784
Accrued liabilities4,5334,8845,5795,4713,3342,966
Debt  8,333 2,00041265
Total current liabilities:5,86714,6608,17410,8807,2546,015
Noncurrent Liabilities
Long-term debt and lease obligation26,07817,32325,10423,11224,53015,072
Long-term debt, excluding current maturities26,07817,32325,10423,11224,53014,775
Capital lease obligations 297
Liabilities, other than long-term debt, including:541178451370103
Deferred tax liabilities, net 7,181
Other liabilities5411784513  
Business combination, contingent consideration, liability     12,21411,948
Other undisclosed liabilities, other than long-term debt     (12,144)(19,026)
Other undisclosed noncurrent liabilities     12,21419,129
Total noncurrent liabilities:26,13217,44025,18823,62536,81434,304
Total liabilities:31,99932,10033,36234,50544,06840,319
Equity
Equity, attributable to parent107,778144,49864,383101,698108,219119,309
Common stock11611655523632
Additional paid in capital446,938444,898320,893309,555237,702186,522
Accumulated other comprehensive income (loss)(605)5942(17)200958
Accumulated deficit(338,671)(300,521)(257,507)(207,892)(129,719)(68,203)
Other undisclosed equity(108,383)(144,493)(63,441)   
Total equity:(605)5942101,698108,219119,309
Other undisclosed liabilities and equity108,383144,49363,441   
TOTAL LIABILITIES AND EQUITY:139,777176,59897,745136,203152,287159,628

Income Statement (P&L) ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Revenues   257   
Gross profit:   257   
Operating expenses(38,839)(41,477)(49,557)(79,025)(70,045)(29,956)
Operating loss:(38,839)(41,477)(49,300)(79,025)(70,045)(29,956)
Nonoperating income (expense)
(Other Nonoperating Income (Expense))
689(1,537)(315)85218(3,475)
Interest and debt expense   (507)(582)(468)(1,816)
Loss from continuing operations before equity method investments, income taxes:(38,150)(43,014)(50,122)(78,755)(70,495)(35,247)
Other undisclosed income from continuing operations before income taxes   5075824681,816
Loss from continuing operations before income taxes:(38,150)(43,014)(49,615)(78,173)(70,027)(33,431)
Income tax benefit     8,5113,634
Loss from continuing operations:(38,150)(43,014)(49,615)(78,173)(61,516)(29,797)
Loss before gain (loss) on sale of properties:(43,014)(49,615)(78,173)(61,516)(29,797)
Net loss attributable to parent:(38,150)(43,014)(49,615)(78,173)(61,516)(29,797)
Preferred stock dividends and other adjustments      (578)
Other undisclosed net loss available to common stockholders, basic      (404)
Net loss available to common stockholders, diluted:(38,150)(43,014)(49,615)(78,173)(61,516)(30,779)

Comprehensive Income ($ in thousands)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(38,150)(43,014)(49,615)(78,173)(61,516)(29,797)
Comprehensive loss:(38,150)(43,014)(49,615)(78,173)(61,516)(29,797)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(610)(937)959(217)(758)1,549
Comprehensive loss, net of tax, attributable to parent:(38,760)(43,951)(48,656)(78,390)(62,274)(28,248)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: